Nesprin-2 is a Novel Scaffold Protein for Telethonin and FHL-2 in the Cardiomyocyte Sarcomere

Chen Li,Derek T. Warren,Can Zhou,Shanelle De Silva,Darren G. S. Wilson,Mitla Garcia-Maya,Matthew A. Wheeler,Peter Meinke,Greta Sawyer,Elisabeth Ehler,Manfred Wehnert,Li Rao,Qiuping Zhang,Catherine M. Shanahan
DOI: https://doi.org/10.1016/j.jbc.2024.107254
IF: 5.485
2024-01-01
Journal of Biological Chemistry
Abstract:Nesprins comprise a family of multi-isomeric scaffolding proteins, forming the linker of nucleoskeleton-andcytoskeleton complex with lamin A/C, emerin and SUN1/2 at the nuclear envelope. Mutations in nesprin-1/-2 are associated with Emery-Dreifuss muscular dystrophy (EDMD) with conduction defects and dilated cardiomyopathy (DCM). We have previously observed sarcomeric staining of nesprin-1/-2 in cardiac and skeletal muscle, but nesprin function in this compartment remains unknown. In this study, we show that specific nesprin-2 isoforms are highly expressed in cardiac muscle and localize to the Z-disc and I band of the sarcomere. Expression of GFP-tagged nesprin-2 giant spectrin repeats 52 to 53, localized to the sarcomere of neonatal rat cardiomyocytes. Yeast two-hybrid screening of a cardiac muscle cDNA library identified telethonin and four-and-half LIM domain (FHL)-2 as potential nesprin-2 binding partners. GST pull-down and immunoprecipitation confirmed the individual interactions between nesprin-2/telethonin and nesprin-2/FHL2, and showed that nesprin-2 and telethonin binding was dependent on telethonin phosphorylation status. Importantly, the interactions between these binding partners were impaired by mutations in nesprin-2, telethonin, and FHL-2 identified in EDMD with DCM and hypertrophic cardiomyopathy patients. These data suggest that nesprin-2 is a novel sarcomeric scaffold protein that may potentially participate in the maintenance and/or regulation of sarcomeric organization and function.
What problem does this paper attempt to address?